Caplin Point Laboratories Ltd
Pharmaceuticals - Indian - Formulations
BSE Code:	524742	NSE Symbol:	CAPLIPOINT	P/E :	47.93
ISIN Demat:	INE475E01026	Div & Yield %:	0.26	EPS :	44.66
Book Value:	223.77	Market Cap (Rs. Cr.):	16,269.54	Face Value :	2

Date	Headline
04-Jun-25	Caplin Point Laboratories announces acquisition of Triwin Pharma S.A DE C.V
15-May-25	Board of Caplin Point Laboratories recommends dividend
14-May-25	Caplin Steriles receives USFDA approval for Haloperidol Decanoate Injection
08-May-25	Caplin Point Laboratories to conduct board meeting
07-May-25	Caplin Point Laboratories to conduct board meeting
23-Apr-25	Caplin Steriles receives USFDA approval for Phytonadione Injectable Emulsion
26-Feb-25	Caplin Steriles receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solu
05-Feb-25	Caplin Steriles receives USFDA approval for Procainamide Hydrochloride Injection
01-Feb-25	Caplin Point Laboratories to hold board meeting
17-Jan-25	Caplin Point Laboratories receives USFDA approval for Levetiracetam in Sodium Chloride Injection

Company Snapshot